News
Gland Pharma's JNPC facility completes USFDA inspection
24-Jun-2025 | 11:12
Gland Pharma announced that following the Pre-approval inspection (PAI) for Sterile APIs at the Company's Facility at JNPC, Visakhapatnam between 19 February 2025, and 25 February 2025; the Company has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection.
Powered by Capital Market - Live News